SCHEMBL7983184

SCHEMBL7983184

COc1cc2nc(NC3CCCCC3)c3cncn3c2cc1OC

nearest known ligand 0.62

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
LCK P06239 4/20 0.62
CCR4 P51679 10/20 0.51
PDGFRB P09619 3/20 0.50
PDGFRA P16234 3/20 0.50
EHMT2 Q96KQ7 2/20 0.47
EHMT1 Q9H9B1 1/20 0.47
NSD2 O96028 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7979976 0.77 LCK (1.00) LCK
SCHEMBL7984166 0.75 LCK (0.81) LCK
SCHEMBL7983098 0.74 LCK (1.00) LCK
SCHEMBL7983189 0.74 LCK (0.71) LCKPDGFRBPDGFRA
SCHEMBL7979982 0.74 LCK (0.78) LCK
SCHEMBL7982985 0.74 LCK (0.78) LCK
SCHEMBL7980192 0.72 LCK (0.72) LCK
SCHEMBL7988026 0.72 LCK (0.69) LCK
SCHEMBL7223653 0.72 LCK (0.56) LCK
SCHEMBL7981211 0.71 LCK (0.58) LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US claimed
WO-1999009845-A1 IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-04 WO claimed
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US disclosed
WO-1999009845-A1 IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-04 WO disclosed